Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiting Cao

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Managed Care & Specialty Pharmacy|September 27, 2016
Biopsy Procedures and Molecular Testing Utilization and Related Costs in Patients with Metastatic Lung CancerReshma Shinde, Xiting Cao, Smita Kothari
Statistics in Medicine|December 14, 2011
A framework for joint modeling and joint assessment of efficacy and safety endpoints for probability of success evaluation and optimal dose selectionWeili He, Xiting Cao, Lu Xu
Journal of Applied Statistics|March 30, 2013
Empirical null distribution based modeling of multi-class differential gene expression detectionXiting Cao, Baolin Wu, Marshall I Hertz
Clinical Lung Cancer|May 10, 2016
Treatment Patterns for Advanced Non-Small-cell Lung Cancer After Platinum-containing Therapy in U.S. Community Oncology Clinical PracticeCaroline McKay, Thomas Burke, Xiting Cao, et al.
Clinical Therapeutics|June 29, 2015
Systematic Literature Review and Meta-analysis of Medication Adherence With Once-weekly Versus Once-daily TherapyKristy Iglay, Xiting Cao, Panagiotis Mavros, et al.
Clinical Genitourinary Cancer|May 9, 2018
Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With ChemotherapyKyle Flannery, Xiting Cao, Jinghua He, et al.
Plos One|November 9, 2018
Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United StatesVamsidhar Velcheti, Pallavi D Patwardhan, Frank Xiaoqing Liu, et al.
Plos One|June 24, 2017
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology settingAmy P Abernethy, Ashwini Arunachalam, Thomas Burke, et al.
Clinical Therapeutics|January 29, 2015
Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United KingdomXiting Cao, Flavia Ejzykowicz, Dena R Ramey, et al.
Future Oncology (London, England)|September 26, 2018
Treatment patterns and outcomes for patients with advanced melanoma in US oncology clinical practicesEric D Whitman, Frank Xiaoqing Liu, Xiting Cao, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Managed Care & Specialty Pharmacy|September 27, 2016
Biopsy Procedures and Molecular Testing Utilization and Related Costs in Patients with Metastatic Lung CancerReshma Shinde, Xiting Cao, Smita Kothari
Statistics in Medicine|December 14, 2011
A framework for joint modeling and joint assessment of efficacy and safety endpoints for probability of success evaluation and optimal dose selectionWeili He, Xiting Cao, Lu Xu
Journal of Applied Statistics|March 30, 2013
Empirical null distribution based modeling of multi-class differential gene expression detectionXiting Cao, Baolin Wu, Marshall I Hertz
Clinical Lung Cancer|May 10, 2016
Treatment Patterns for Advanced Non-Small-cell Lung Cancer After Platinum-containing Therapy in U.S. Community Oncology Clinical PracticeCaroline McKay, Thomas Burke, Xiting Cao, et al.
Clinical Therapeutics|June 29, 2015
Systematic Literature Review and Meta-analysis of Medication Adherence With Once-weekly Versus Once-daily TherapyKristy Iglay, Xiting Cao, Panagiotis Mavros, et al.
Clinical Genitourinary Cancer|May 9, 2018
Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With ChemotherapyKyle Flannery, Xiting Cao, Jinghua He, et al.
Plos One|November 9, 2018
Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United StatesVamsidhar Velcheti, Pallavi D Patwardhan, Frank Xiaoqing Liu, et al.
Plos One|June 24, 2017
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology settingAmy P Abernethy, Ashwini Arunachalam, Thomas Burke, et al.
Clinical Therapeutics|January 29, 2015
Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United KingdomXiting Cao, Flavia Ejzykowicz, Dena R Ramey, et al.
Future Oncology (London, England)|September 26, 2018
Treatment patterns and outcomes for patients with advanced melanoma in US oncology clinical practicesEric D Whitman, Frank Xiaoqing Liu, Xiting Cao, et al.
Pageof 4